Familial features affecting the melanoma risk in CDKN2A-negative melanoma families: a study based on the Swedish Cancer Registry

Acta Oncol. 2023 Dec;62(12):1967-1972. doi: 10.1080/0284186X.2023.2265052. Epub 2023 Nov 25.

Authors

Hildur Helgadottir^{1

2}, Karina Schultz^{1

2}, Jan Lapins^{3

4}, Veronica Höiom^{1

2}

Affiliations

¹ Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
² Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
³ Department of Dermatology, Karolinska University Hospital, Stockholm.
⁴ Dermatology and Venereology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

PMID: 37801364
DOI: 10.1080/0284186X.2023.2265052

No abstract available

MeSH terms

Cyclin-Dependent Kinase Inhibitor p16 / genetics
Genetic Predisposition to Disease
Germ-Line Mutation
Humans
Melanoma* / epidemiology
Melanoma* / genetics
Registries
Skin Neoplasms* / epidemiology
Skin Neoplasms* / genetics
Sweden / epidemiology

Substances

Cyclin-Dependent Kinase Inhibitor p16
CDKN2A protein, human